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Abstract: It is about a 33-year-old female, with a 36 weeks uncomplicated pregnancy and 
with signs of increased intracranial pressure. Hours after admission and an obstetric 
evaluation, uterine contraction started and the patient was taken to the delivery room, 
where she presented a partial motor seizure on the left side with secondary generalization 
and urine emission. A caesarean section was performed without fetal or maternal 
complications. The urgent MRI gadolinium-enhanced brain scan revealed a 39/50/54 mm 
tumoral mass having an aspect of an anterior third falx cerebri meningioma. The patient 
was transferred to our neurosurgical department and afterwards surgery was performed 
with gross total removal of the tumoral mass. Histological examination revealed atypical 
meningioma with direct invasion into the adjacent brain parenchyma. A week later she was 
discharged from the hospital in good condition. One month after surgery, a contrast-
enhanced magnetic resonance imaging of the brain did not reveal any signs of tumor 
recurrence or residual tumor. Our recommendation is for postpartum surgery when is 
possible. Urgent neurosurgical interventions should be made in case of patients with 
malignant tumors, active hydrocephalus or benign intracranial tumor such as meningioma 
associated with signs of impending herniation, progressive neurological deficits. 
 
Introduction 
Intracranial tumors in pregnant women 
are rare, with an estimated incidence of about 
seven cases per 125.000 pregnancies. The first 
case of a pregnant woman with a brain tumor 
was described by Bernard in 1898. (1, 2, 3, 4, 5) 
The occurrence of a meningioma during 
pregnancy is also rare, comparable with that in 
non-pregnant women in the same age group. 
(1, 2, 3, 4) 
Particular for meningiomas is the 
expression of hormone receptors. These 
tumors response to the increased level of 
serum progesterone during the second half of 
pregnancy by accelerating its growth. Tumor 
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enlarges by fluid retention, enhanced 
vascularity and therefore patients may become 
symptomatic. (1) 
The clinical presentation with signs and 
symptoms of elevated intracranial pressure, 
focal seizures, lateralising neurological 
deficits, abnormal funduscopic examination 
suggests the diagnosis of an intracranial mass 
and should not be confused with hyperemesis 
gravidarium, eclampsia or puerperal 
psychosis. (1, 5) 
Magnetic resonance imaging of the brain is 
the method of choice for prompt diagnosis of 
meningioma during pregnancy. (1) 
The management strategy for intracranial 
tumors during pregnancy should be 
individualised and include mainly surgery. 
Surgery during pregnancy associates a great 
risk for fetus and also for the mother. The 
general recommendation is for caesarean 
section as first surgery and then the 
neurosurgical intervention when the patient’s 
neurological status and the gestational age 
allow. (9)  
Urgent neurosurgical interventions should 
be made in case of patients with malignant 
tumors, active hydrocephalus or benign 
intracranial tumor such as meningioma 
associated with signs of impending herniation, 
progressive neurological deficits. (5) 
Radiotherapy and mifepristone are 
recommended for unresectable or recurrent 
meningioma. (4)  
Case report 
A 33-year-old right-handed female, 36 
weeks pregnant presented to her obstetrician 
with one month history of headache, 24 hours 
before admission she accused repeated 
vomiting. An obstetric evaluation revealed an 
uncomplicated pregnancy at 36 weeks. The 
ultrasound and the fetal monitoring was in 
normal ranges. Four hours from admission 
uterine contraction started and the patient was 
taken to delivery room, here she presented a 
partial motor seizure on the left side with 
secondary generalization and urine emission. 
After seizure the patient was drowsy, her 
mental status depressed progressively. She was 
urgent transfer to operation room and 
caesarean section was performed under 
general endotracheal anesthesia. The 
caesarean section went well without fetal or 
maternal complications. 
After delivery the patient underwent 
imaging investigation. The urgent IRM scan of 
the brain with gadolinium revealed a 39/50/54 
mm tumoral mass with the same density, 
which captured intense and homogeneous 
contrast. The tumor was plated on the anterior 
1/3 of the falx cerebri on the right side. Midline 
was shifted to the left side by about 14 mm. 
The tumor was also accompanied by 
significant perilesional edema. (Figure 1) 
In this stage the patient was transferred to 
our neurosurgical department. On admission 
the patient was afebrile with normal vital signs. 
The general examination was normal. The 
neurological exam revealed impaired 
consciousness, left-sided hemiparesis with a 
left-sided pronator drift. Reflexes were 
diminished on the left side and the Babinski 
sign was present on the left side. The 
funduscopic examination showed bilateral 
papillary edema. 
Anticonvulsant and corticoid therapy was 
immediately started and the neurological 
status of the patient improved.  
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Figure 1 - Preoperative MRI. Well-defined, contrast enhancing, extraaxial tumor, attached to the anterior third of 
falx cerebri, with mass effect and surrounding edema 
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Figure 2 - Postoperative MRI. Complete tumor resection, no tumor recurrence 
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After few days the neurosurgical operation 
was scheduled. Under general anesthesia a 
right frontal craniotomy was performed. The 
tumor was easily identified as a hypervascular 
mass adherent to the anterior 1/3 of the falx. A 
peritumoral plane of dissection was developed 
and tumor was resected with coagulation of its 
falx adhesions. 
Histological examination revealed atypical 
meningioma with direct invasion into the 
adjacent brain parenchyma. 
After surgery patient was conscious, with 
minimal left hemiparesis and no seizure. She 
was discharged from the hospital 7 days later, 
in good condition. 
Approximately one month after surgery, a 
contrast-enhanced magnetic resonance 
imaging of the head was performed; it does not 
reveal any signs of tumor recurrence or 
residual tumor. (Figure 2) 
Discussion 
Meningioma is the most common primary 
intracranial tumor in the adult population; it is 
a slow growing extra-axial brain neoplasm that 
arise from the arachnoid cells. This tumor 
accounts for 10-20% of all central nervous 
system neoplasms with an incidence among 
women of 3 in 100.000. The occurrence of a 
meningioma during pregnancy is rare because 
pregnant women tend to be young and 
healthy, so the general incidence of this 
pathology does not exceed that of 
nonpregnant women in the same age group. 
(1, 2, 3, 4) 
In 1898, Bernard described the first case of 
a pregnant woman with a brain tumor. In 
1937, Hagedoorn presented a documented 
study about the effects of pregnancy on 
intracranial meningioma. (5, 6, 7). The 
relationship between pregnancy and the rapid 
increase of neurologic symptoms in women 
with meningioma was first described by 
Cushing and Eisenhardt. (8, 9) 
The predominance of meningiomas in 
women and accelerated growth during luteal 
phase of menstrual cycle and during 
pregnancy is determined by the expression of 
progesterone and estrogen receptors. Swensen 
and Kirsch noted in their study from 2002 that 
meningiomas express estrogen receptors in 
13% of cases and progesterone receptors in 69 
% of cases. (4, 10) 
Meningiomas may also express hormone 
receptors not only for progesterone and 
estrogen but also for androgen, placenta 
growth factor andother exogenous hormones. 
(1, 11, 12, 13) These tumors response to 
increased level of serum progesterone in the 
second half of pregnancy by accelerated 
growth, so the tumor enlarges by fluid 
retention and enhanced vascularity. (1, 9, 14) 
The acceleration of meningioma growth in 
the second or third trimesters of pregnancy 
may be determined also by the absence of 
Luteinising hormone and Follicle-stimulating 
hormone and by the falling level of Human 
chorionic gonadotropin in these stages of 
pregnancy. These observations were made in a 
vitro study on meningiomas by Boyle-Walesh, 
Shenkin and White in their paper published in 
1995. (15) 
The phenotypic profile of hormone 
receptor in meningioma has been classified 
into a high percentage of tumors displaying 
high level of progesterone receptor (PR); a 
smaller subgroup containing moderate 
concentrations of androgen receptor (AR); the 
level of estrogen receptor (ER) has been 
equivocal, ranging from low to virtually 
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undetectable by immunohistochemistry. (9, 
16) In our days, Positron emission 
tomography helps us to measure in vivo the 
receptor density and occupancy in this type of 
tumor. (17) 
The main signs and symptoms of 
intracranial meningioma are headache, 
vomiting and seizure, this clinical picture can 
be confused with hyperemesis gravidarium, 
puerperal psychosis in the first trimester of 
pregnancy or with eclampsia in late 
pregnancy. (1, 5) The presence of papillary 
edema, visual disturbances, focal seizure, and 
lateralizing neurological deficits should 
suggest an intracranial lesion. 
The appearance or aggravation of signs and 
symptoms during pregnancy is determined by 
one of the following mechanisms: maternal 
metabolic changes causing fluid retention, 
vascular engorgement, and increased edema 
or positive hormone receptors on tumor cells 
with dramatic growth of the meningioma. The 
presence of progesterone receptors on tumor 
cells is correlated with worsening symptoms of 
meningioma. (5, 18, 19) 
Therefore, in women in late pregnancy 
presenting with symptoms of increased 
intracranial pressure and focal signs or 
presenting with progressive worsening of 
neurological symptoms, an intracranial 
pathology should be considered and further 
imagistic investigations should be made to 
establish correct diagnosis. 
Magnetic resonance imaging of the brain is 
the method of choice for prompt diagnosis of 
meningioma during pregnancy. We must note 
its limitations due to the inability to use 
contrast agents during pregnancy. The CT 
scan is not recommended because carries the 
risk of radiation damage. (1) 
The management strategy for intracranial 
tumors during pregnancy should be made 
depending on patient’s physical status, 
localization of the tumor, gestational age and 
other concomitant factors. Surgical excision is 
the treatment of choice for intracranial 
meningiomas but surgical intervention should 
be avoided during pregnancy when is possible 
because of the increased risk to both mother 
and fetus. Postpartum surgery of meningioma 
is recommended by most authors in the 
literature, with non-surgical treatment of the 
increased intracranial pressure until fetal lung 
maturity is reached. (9, 18) Others consider 
that non-invasive fetal monitoring such as 
fetal biophysical profit scoring system and 
umbilical artery Doppler velocimetry, and 
neuroanesthesia and microsurgical techniques 
permit a safe neurosurgical treatment of 
intracranial tumors during pregnancy. (5) 
Our recommendation is for postpartum 
surgery when is possible. Urgent neurosurgical 
interventions should be made in case of 
patients with malignant tumors, active 
hydrocephalus or benign intracranial tumor 
such as meningioma associated with signs of 
impending herniation, progressive 
neurological deficits. (5) 
Neurosurgery during pregnancy associates 
important risks for the mother. General 
endotracheal anesthesia is complicated by the 
upper airway mucosal edema, decreased 
functional residual capacity, venous 
engorgement, water retention, increased risk 
for reflux and aspiration, weight gain. In 
pregnancy the use of diuretics is not 
recommended so the neurosurgeon will 
confront with the lack of brain relaxation and 
that makes the operation more difficult. The 
surgery can also induce labor and it can be 
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associated with important blood loss. (1, 20, 
21, 22) 
Brain surgery can also harm the fetus, it can 
cause stillbirth, birth defects (in the early stage 
of pregnancy), premature labor, premature 
delivery or fetal asphyxia. (1, 23) 
From another perspective, if the 
neurosurgery is not made, the tumor may 
enlarge, and it can cause seizure or even 
herniation. (1, 21, 24) 
Complete surgical resection is the only 
definitive cure for meningiomas. Complete 
resection is determined by the tumor site. 
Mirimanoff et al, consider that total excision 
depends on the accessibility of the tumor (28% 
for sphenoid wing and 96% for convexity 
meningiomas). High risk of recurrence is also 
associated with atypical or anaplastic 
meningioma and with a proliferative index 
greater than or equal to 20%. (25, 26, 27) 
Medical treatment before and after surgery 
includes corticosteroids, the usual dose is 2-4 
mg of dexamethasone every 6 hour. 
Anticonvulsant medication is also needed, 
preferably monotherapy. The patients on 
anticonvulsant therapy should receive folic 
acid and supplemental vitamin-K1 three 
weeks before and during confinement to 
minimalize the risk of drug induced neural 
tube defects or blood dyscrasias. Manitol 
should be administrated only for acute 
emergency because sudden decrease in plasma 
volume might compromise uteroplacentar 
perfusion and put the fetus to risk. (28, 29, 30) 
Mifepristone, hidroxyurea as anti-
progesterones, temozolomide or radiotherapy 
can be used for unresectable benign 
meningioma, recurrent or malignant 
meningioma. Interferon as an angiostatic may 
also be considered. (31, 32, 33) 
Conclusions 
The management of a pregnant woman 
with an intracranial meningioma should be 
individualized and the final decision must be 
made on the intracranial pathology, 
gestational age and not least to be taken into 
account the patient’s wishes. Pregnant women 
with repeated vomiting, nausea and headache 
should be examined with care and an 
intracranial pathology should be considered. 
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